Comments: 4.1c) If sub-recipients will be involved in implementation, does the Concept Note describe their role and identify any anticipated challenges, if applicable, and the intended strategies to address them? (a) Not addressed, (b) Addressed but requiring major improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: Does it describe whether sub-recipients have been identified, and what type of management arrangements are likely to be put in place. If sub-recipients have not been identified, does it describe the time-bound process that will be used by the PR(s) to transparently select sub-recipients? (a) Not addressed, (b) Addressed but requiring major improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: 4.1d) Does the Concept Note clearly describe how nominated PR(s) will coordinate with their respective sub-recipients? (a) Not addressed, (b) Addressed but requiring improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: 4.1e) Does the Concept Note describe how representatives of organizations, people living with the three diseases and key populations will actively participate in the implementation of the funding request? (a) Not addressed, (b) Addressed but requiring improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: Has the applicant developed an implementation arrangement diagram showing the selected key actors responsible for program delivery? Note: this will need to be prepared for the grant-making stage of the funding process and will be used to launch the capacity assessment. It should include:
Comments: 4.1c) If sub-recipients will be involved in implementation, does the Concept Note describe their role and identify any anticipated challenges, if applicable, and the intended strategies to address them? (a) Not addressed, (b) Addressed but requiring major improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: Does it describe whether sub-recipients have been identified, and what type of management arrangements are likely to be put in place. If sub-recipients have not been identified, does it describe the time-bound process that will be used by the PR(s) to transparently select sub-recipients? (a) Not addressed, (b) Addressed but requiring major improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: 4.1d) Does the Concept Note clearly describe how nominated PR(s) will coordinate with their respective sub-recipients? (a) Not addressed, (b) Addressed but requiring improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: 4.1e) Does the Concept Note describe how representatives of organizations, people living with the three diseases and key populations will actively participate in the implementation of the funding request? (a) Not addressed, (b) Addressed but requiring improvement, (c) Addressed and requiring minor improvement, (d) Adequately addressed Comments: Has the applicant developed an implementation arrangement diagram showing the selected key actors responsible for program delivery? Note: this will need to be prepared for the grant-making stage of the funding process and will be used to launch the capacity assessment. It should include:
Checklist%20for%20TB-HIV%20CN%20review.docx